Sponsor of the Day:
Jerkmate
https://www.quanterix.com/news-media-center/press-releases/quanterix-to-report-first-quarter-2026-financial-results-on-may-6-2026/
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026 | Quanterix
Apr 24, 2026 - BILLERICA, Mass. – April 24, 2026 – Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from
report first quarter2026 financial resultsquanterixmay
https://www.quanterix.com/webinars-videos/webinars/p-tau-205-and-212-emerging-biomarkers-for-alzheimers-disease-research/
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research | Quanterix
Dec 26, 2025 - Phosphorylated tau (p-Tau) biomarkers have become a cornerstone of Alzheimer’s disease research and diagnosis—but not all p-Tau species offer the same
disease researchptau205212
https://www.quanterix.com/contact-us/
Contact Us | Quanterix
Mar 5, 2026 - Discovery Fueled by Ultra-Sensitivity
usquanterix
https://www.quanterix.com/
Ultra-Sensitive Biomarker Detection | Quanterix
Feb 27, 2026 - Our revolutionary biomarker testing technology, Simoa®, is helping researchers advance the science of precision health. Learn more!
ultra sensitivebiomarkerdetectionquanterix
https://www.quanterix.com/custom-assay-development/
Custom Immunoassay Development | Quanterix
Dec 29, 2025 - Use your own proprietary reagents in combination with the Homebrew Immunoassay Development Kit to create custom SIMOA assays. Learn more.
customimmunoassaydevelopmentquanterix